Table 1. Tumor incidence rate in transgenic mice after N-methyl-N-nitrosourea treatment.
Genotype | Squamous cell carcinoma/papilloma (Stomach) | Squamous cell papilloma (Skin) | Malignant lymphoma (Hematopoietic system) |
Ras−HOL− | 6.7%* | 0% | 60% |
Ras+HOL− | 87.5% | 37.5% | 50% |
Ras−HOL+ | 0% | 0% | 55.6% |
Ras+HOL+ | 62.5% | 37.5% | 75% |
*Tumor incidence rate. Carcinogenicity test of 15 mice from each of the following offspring type: CB6F1-albino (Ras−HOL−), CB6F1-albino-rasH2 (Ras+HOL−), C6F1-albino-HOL (Ras−HOL+), and CB6F1-albino-rasH2-HOL (Ras+HOL+) were performed by administering N-methyl-N-nitrosourea. The mice that were alive at the end of the experimental period were necropsied, and systemic visual observations were performed.